250: SVB's long biotech shadow, pushy AI algorithms, & Icahn v. Illumina

STAT reporter Bob Herman joins us to explain how treatment algorithms powered by artificial intelligence are being used more frequently by Medicare Advantage plans to deny claims, even when continued treatment is medically justified. We’ll also discuss the latest news in the life sciences, including the continued fallout of the run on Silicon Valley Bank, the return of Carl Icahn, and a long-awaited pharmaceutical megadeal.

Episode metadata supplied by the publisher feed · Published Mar 16, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

250: SVB's long biotech shadow, pushy AI algorithms, & Icahn v. Illumina

0:00 35:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 35 minutes long.

When was this The Readout Loud episode published?

This episode was published on March 16, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!